First Wave BioPharma Inc
General ticker "FWBI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $7.9M
First Wave BioPharma Inc does not follow the US Stock Market performance with the rate: -24.8%.
Estimated limits based on current volatility of 6.6%: low 2.01$, high 2.29$
Factors to consider:
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 predicted range: [62.23$, 296.75$]
- 2023-12-31 to 2024-12-30 predicted range: [29.63$, 120.35$]
Financial Metrics affecting the FWBI estimates:
- Negative: Non-GAAP EPS of -3650.19 <= 0.08
- Negative: Operating Income to Revenue ratio of -1.00 <= 0.01
- Negative: Operating Cash Flow per share of -622.19 <= 0.20
- Negative: negative Net Income
- Negative: Industry Earnings per Price (median) of -0.27 <= 0.01
Short-term FWBI quotes
Long-term FWBI plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $26.43MM | $59.06MM | $12.68MM |
| Operating Income | $-26.43MM | $-59.06MM | $-12.68MM |
| Non-Operating Income | $-6.24MM | $0.52MM | $-0.24MM |
| Interest Expense | $5.84MM | $0.01MM | $0.02MM |
| R&D Expense | $19.14MM | $38.32MM | $0.69MM |
| Income(Loss) | $-32.67MM | $-58.54MM | $-12.92MM |
| Profit(Loss) | $-32.67MM | $-58.54MM | $-12.92MM |
| Stockholders Equity | $-2.64MM | $-7.82MM | $2.74MM |
| Assets | $12.92MM | $11.79MM | $5.44MM |
| Operating Cash Flow | $-11.22MM | $-32.29MM | $-22.34MM |
| Investing Cash Flow | $0.09MM | $-10.32MM | $0.00MM |
| Financing Cash Flow | $17.05MM | $44.76MM | $15.74MM |
| Earnings Per Share* | $-57,194.08 | $-27,799.23 | $-461.72 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.